Literature DB >> 16799556

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing.

Roman K Thomas1, Elizabeth Nickerson, Jan F Simons, Pasi A Jänne, Torstein Tengs, Yuki Yuza, Levi A Garraway, Thomas LaFramboise, Jeffrey C Lee, Kinjal Shah, Keith O'Neill, Hidefumi Sasaki, Neal Lindeman, Kwok-Kin Wong, Ana M Borras, Edward J Gutmann, Konstantin H Dragnev, Ralph DeBiasi, Tzu-Hsiu Chen, Karen A Glatt, Heidi Greulich, Brian Desany, Christine K Lubeski, William Brockman, Pablo Alvarez, Stephen K Hutchison, J H Leamon, Michael T Ronan, Gregory S Turenchalk, Michael Egholm, William R Sellers, Jonathan M Rothberg, Matthew Meyerson.   

Abstract

The sensitivity of conventional DNA sequencing in tumor biopsies is limited by stromal contamination and by genetic heterogeneity within the cancer. Here, we show that microreactor-based pyrosequencing can detect rare cancer-associated sequence variations by independent and parallel sampling of multiple representatives of a given DNA fragment. This technology can thereby facilitate accurate molecular diagnosis of heterogeneous cancer specimens and enable patient selection for targeted cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16799556     DOI: 10.1038/nm1437

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  127 in total

Review 1.  Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges.

Authors:  Laura E MacConaill; Paul Van Hummelen; Matthew Meyerson; William C Hahn
Journal:  Cancer Discov       Date:  2011-09       Impact factor: 39.397

Review 2.  Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.

Authors:  Xi Lin; Wenxue Tang; Shoeb Ahmad; Jingqiao Lu; Candice C Colby; Jason Zhu; Qing Yu
Journal:  Hear Res       Date:  2012-01-14       Impact factor: 3.208

3.  What Next? The Next Transit from Biology to Diagnostics: Next Generation Sequencing for Immunogenetics.

Authors:  Christian Gabriel; Stephanie Stabentheiner; Martin Danzer; Johannes Pröll
Journal:  Transfus Med Hemother       Date:  2011-09-25       Impact factor: 3.747

4.  Multigene amplification and massively parallel sequencing for cancer mutation discovery.

Authors:  Fredrik Dahl; Johan Stenberg; Simon Fredriksson; Katrina Welch; Michael Zhang; Mats Nilsson; David Bicknell; Walter F Bodmer; Ronald W Davis; Hanlee Ji
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-17       Impact factor: 11.205

5.  Nonrandom variations in human cancer ESTs indicate that mRNA heterogeneity increases during carcinogenesis.

Authors:  Marie Brulliard; Dalia Lorphelin; Olivier Collignon; Walter Lorphelin; Benoit Thouvenot; Emmanuel Gothié; Sandrine Jacquenet; Virginie Ogier; Olivier Roitel; Jean-Marie Monnez; Pierre Vallois; Frances T Yen; Olivier Poch; Marc Guenneugues; Gilles Karcher; Pierre Oudet; Bernard E Bihain
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

6.  Low sequencing efforts bias analyses of shared taxa in microbial communities.

Authors:  Leandro N Lemos; Roberta R Fulthorpe; Luiz F W Roesch
Journal:  Folia Microbiol (Praha)       Date:  2012-05-05       Impact factor: 2.099

Review 7.  Direct mutation analysis by high-throughput sequencing: from germline to low-abundant, somatic variants.

Authors:  Michael Gundry; Jan Vijg
Journal:  Mutat Res       Date:  2011-10-12       Impact factor: 2.433

Review 8.  Massively parallel sequencing: the next big thing in genetic medicine.

Authors:  Tracy Tucker; Marco Marra; Jan M Friedman
Journal:  Am J Hum Genet       Date:  2009-08       Impact factor: 11.025

9.  Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.

Authors:  Mariana Fitarelli-Kiehl; Fangyan Yu; Ravina Ashtaputre; Ka Wai Leong; Ioannis Ladas; Julianna Supplee; Cloud Paweletz; Devarati Mitra; Jonathan D Schoenfeld; Sareh Parangi; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2018-10-01       Impact factor: 8.327

10.  De novo induction of genetically engineered brain tumors in mice using plasmid DNA.

Authors:  Stephen M Wiesner; Stacy A Decker; Jon D Larson; Katya Ericson; Colleen Forster; Jose L Gallardo; Chunmei Long; Zachary L Demorest; Edward A Zamora; Walter C Low; Karen SantaCruz; David A Largaespada; John R Ohlfest
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.